A diagnostics startup is developing a blood test that can monitor the impact of chronic disease on the body – and investors are taking notice. Curve Biosciences, which has developed Whole Body ...
Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases. By Pam Belluck and Carl Zimmer Gene-editing therapies offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results